[{"_1":2,"_3":-5,"_4":-5},"loaderData",{"_5":6,"_7":8},"actionData","errors","root",{"_102":103,"_104":57},"routes/item",{"_9":10},"item",{"_11":12,"_13":14,"_15":16,"_17":16,"_18":-5,"_19":-5,"_20":21,"_22":23,"_24":25,"_26":27,"_28":25,"_29":30,"_31":32,"_33":34,"_35":36,"_37":38,"_39":-5,"_38":40,"_41":-5,"_42":-5,"_43":-5,"_44":45,"_46":47,"_48":-5,"_49":50,"_51":52,"_53":54,"_55":36,"_56":57,"_58":-5,"_59":60,"_61":62,"_63":36,"_64":57,"_65":66},"id","o6i21q1abplwpom607pk3jtyn","revision",2,"title",".","originalTitle","summary","reason","source",{"_11":96,"_77":97,"_98":99,"_100":36,"_101":-5},"links",{"_93":94,"_82":95},"publishedAt","2026-04-19T21:41:07.000Z","discoveredAt","2026-10-22T11:08:34.836Z","timelineAt","category","opinion","tags",[],"score",60,"selected",false,"channel","x","story",{"_86":87,"_88":47,"_89":-5,"_90":-5,"_91":92},"insight","digest","conferenceAbstracts","readingMode","full","author","YaleCancer","language","body",{"_66":81,"_82":-5,"_83":84,"_85":57},"outline",[],"relatedStories",[],"indexable","markdownAvailable",true,"group","conference",{"_75":76,"_77":78,"_79":-5,"_80":-5},"engagement",{"_67":68,"_69":70,"_71":72,"_73":74},"posterIsAuthor","hasTranslation","bodyLanguage","zh","heat",14,"likes",13,"replies",0,"reposts",1,"slug","aacr-2026","name","AACR 2026 年会","topic","reading","

.
@DanielColonRios
在 #AACR26 展示了一项研究，揭示 IDH1 突变癌症如何对 #PARP 抑制剂产生耐药性。来自
@GlazerLab
的研究确定了 PARPi 耐药背后的关键通路，并指出了克服耐药性的潜在策略。
@AACR

@SmilowCancer

@OncoAlert

","original","zhKind","translation","complete","authorName","Yale Cancer Center","handle","avatarUrl","quoted","media",[],"aihot","/items/o6i21q1abplwpom607pk3jtyn","https://x.com/YaleCancer/status/2045981039768764628","aacr26-floor","AACR 2026 现场信号","kind","x_search","firstParty","iconUrl","changelogVersion","2026-10-23T01:25","enEditionEnabled"]